Results 171 to 180 of about 153,475 (357)
Mitotane is an adrenolytic drug with cytotoxic effects, registered for the treatment of advanced adrenocortical carcinoma (ACC), a rare but aggressive tumour type with a poor prognosis despite treatment. Recently, the oral multi‐kinase inhibitor cabozantinib has shown promising results as a potential second‐line treatment option.
Annemieke M. Peters van Ton +4 more
wiley +1 more source
Background One of the most common clinical thyroid related disorders is thyroid nodules (TNs). The metabolic syndrome (Mets) frequency rise significantly with age, TNs are prevalent in older adults, and their incidence increases with age.
Fady Nagy L. Mehany +4 more
doaj +1 more source
Malignant carcinoma and skin melanoma neoplasms concomitantly in the thyroid [PDF]
Ali Al‐Harake +8 more
openalex +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
The Potential Diagnostic Utility of TROP-2 in Thyroid Neoplasms
Haiyan Liu, Jianhui Shi, Fan Lin
openalex +1 more source
Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features [PDF]
National Cancer Institute
openalex +1 more source
Synchronous Parathyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features. [PDF]
Alajaimi A +3 more
europepmc +1 more source
X‐ray controlled release strategy in cancer therapy
A comprehensive review on the design principles and current strategies of X‐ray stimulated release systems in cancer therapy, focusing on the X‐ray responsive functional groups and materials as well as discussing the advantages and current challenges of X‐ray controlled release systems in cancer therapy.
Yiling Ruan +5 more
wiley +1 more source
The Value of Relative Size in the Ultrasound Diagnosis of Follicular Thyroid Neoplasm. [PDF]
Zhang S +8 more
europepmc +1 more source

